Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price


29.03.23 / Tradegate WKN: A0MKPR / Name: Cellectis / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Cellectis Nom. Stock

Heavy losses for Cellectis Nom. today as the stock fell by -€0.066 (-3.370%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Cellectis Nom. stock is not clear.
As a result the target price of €3.00 shows a very positive potential of 63.666% compared to the current price of €1.83 for Cellectis Nom..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Cellectis Nom. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Cellectis Nom. in the next few years

G***** c******* t* c**********
W********* I********* f** t** n*** y****
S********** s********
M***** P*******
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Cellectis Nom. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Cellectis Nom. -3.370% -2.655% -15.995% -54.471% -7.889% -76.929% -
Erytech Pharma S.A. -5.110% 18.123% 5.632% -42.274% 153.308% - -
Nanobiotix -2.260% 3.750% -2.639% -48.287% -6.347% -39.361% -73.776%
Transgene S.A. -0.430% 1.314% -6.377% -19.037% 11.985% 54.167% -36.968%


Buy Cellectis Nom.
Show more